Compare JMIA & AORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | JMIA | AORT |
|---|---|---|
| Founded | 2012 | 1984 |
| Country | Germany | United States |
| Employees | N/A | N/A |
| Industry | Catalog/Specialty Distribution | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 852.1M | 975.7M |
| IPO Year | 2018 | 1996 |
| Metric | JMIA | AORT |
|---|---|---|
| Price | $6.34 | $20.54 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 5 |
| Target Price | $16.75 | ★ $49.40 |
| AVG Volume (30 Days) | ★ 1.9M | 727.5K |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 165.62 |
| EPS | N/A | ★ 0.03 |
| Revenue | N/A | ★ $298,836,000.00 |
| Revenue This Year | $22.18 | $14.20 |
| Revenue Next Year | $23.26 | $11.20 |
| P/E Ratio | ★ N/A | $671.00 |
| Revenue Growth | N/A | ★ 18.01 |
| 52 Week Low | $3.63 | $19.16 |
| 52 Week High | $14.72 | $48.25 |
| Indicator | JMIA | AORT |
|---|---|---|
| Relative Strength Index (RSI) | 39.79 | 34.38 |
| Support Level | N/A | $19.49 |
| Resistance Level | $7.66 | $24.70 |
| Average True Range (ATR) | 0.43 | 0.95 |
| MACD | -0.05 | 0.44 |
| Stochastic Oscillator | 9.59 | 24.35 |
Jumia Technologies AG is the pan-African e-commerce platform. The company's platform consists of a marketplace that connects sellers with consumers. The logistics services of the company enables the shipment and delivery of packages from sellers to consumers, and the company's payment service facilitates transactions among participants active on its platform in selected markets. The company generates revenue from first-party sales, third-party sales, marketing and advertising, and the provision of other services. Its geographical segments are West Africa, North Africa, East & South Africa, Europe, and United Arab Emirates. The firm generates majority of its revenue from the West Africa segment.
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.